维普中文期刊产品整合服务

Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study

查看全文 作  者:Decebal [1]Fodor;Ioan [1]Jung;Sabin [1]Turdean;Catalin [1]Satala;Simona [1,2]Gurzu 高影响力作者 机构地区:[1]Department of Pathology, University of Medicine,Pharmacy, Sciences and Technology;[2]Research Center (CCAMF), University of Medicine, Pharmacy, Sciences and Technology高影响力机构 出  处:《World Journal of Hepatology》索引2019年第11卷第3期,共11页高影响力期刊 摘  要:BACKGROUND Although hepatocellular carcinoma(HCC) is one of the most vascular solid tumors, antiangiogenic therapy has not induced the expected results.AIM To uncover immunohistochemical(IHC) aspects of angiogenesis in HCC.METHODS A retrospective cohort study was performed and 50 cases of HCC were randomly selected. The angiogenesis particularities were evaluated based on the IHC markers Cyclooxygenase-2(COX-2), vascular endothelial growth factor(VEGF) A and the endothelial area(EA) was counted using the antibodies CD31 and CD105.RESULTS The angiogenic phenotype evaluated with VEGF-A was more expressed in small tumors without vascular invasion(pT1), whereas COX-2 was rather expressed in dedifferentiated tumors developed in non-cirrhotic liver. The CD31-related EA value decreased in parallel with increasing COX-2 intensity but was higher in HCC cases developed in patients with cirrhosis. The CD105-related EA was higher in tumors developed in patients without associated hepatitis.CONCLUSION In patients with HCC developed in cirrhosis, the newly formed vessels are rather immature and their genesis is mediated via VEGF. In patients with non-cirrhotic liver, COX-2 intensity and number of mature neoformed vessels increases in parallel with HCC dedifferentiation. 关 键 词:HEPATOCELLULAR carcinoma ANGIOGENESIS ENDOTHELIAL area ANTIANGIOGENIC therapy
相关文献

参考文献(39)

引证文献(7)

耦合文献(45)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费